Reuters logo
4 months ago
BRIEF-Akari Therapeutics says Edison Investment has withdrawn report titled "Akari's coversin matches soliris in phase II"
April 27, 2017 / 10:52 AM / 4 months ago

BRIEF-Akari Therapeutics says Edison Investment has withdrawn report titled "Akari's coversin matches soliris in phase II"

April 27 (Reuters) - Akari Therapeutics Plc

* Akari therapeutics plc says edison investment research ltd has withdrawn the report titled "akari's coversin matches soliris in phase ii" Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below